EE315 Cost-Effectiveness Analysis of Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes in China
Abstract
Authors
L Liu R Zhen COL Ung Y Shen Y Zhang S Han R Jia J Qiao H Hu L Guo
L Liu R Zhen COL Ung Y Shen Y Zhang S Han R Jia J Qiao H Hu L Guo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now